Skip to Content

ZA-35 37.5 mg (Venlafaxine Extended Release 37.5 mg)

Pill imprint ZA-35 37.5 mg has been identified as Venlafaxine hydrochloride extended release 37.5 mg.

Venlafaxine is used in the treatment of major depressive disorder; fibromyalgia; anxiety; anxiety and stress; hot flashes (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Venlafaxine hydrochloride extended release 37.5 mg ZA-35 37.5 mg
Discount Card Promo
Venlafaxine hydrochloride extended release
ZA-35 37.5 mg
37.5 mg
Gray & White
Prescription only
Drug Class:
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Zydus Pharmaceuticals USA Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
cetostearyl alcohol
microcrystalline cellulose
ethyl acrylate - methyl methacrylate copolymer
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferrosoferric oxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
60429-0121 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.